Genscript Biotech Corporation

HK$30.38As of Sun 8 Nov 2026, 12:00 UTC
HKEX:1548Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR 25.30%
Div yield —
ROE (15.33%)
Biotechnology
Beta (5Y) 0.92
PE TTM —
TSR TTM 88.70%
Mkt cap HK$69.28B
ROIC 3.67%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$34
10.62%
189.13%
Hold 8|4|8|2|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.60
0.58
0.61
0.60
20.07%
21.29%
16.11%
6.66%
Revenue$B
5.632
5.825
5.900
6.170
2.08%
5.08%
5.54%
12.81%
Peers (US$8.837B)
Cap (US$)
PE
10.23B
—
4.826B
4.047x
8.916B
40.87x
Capital
TTM
5Y
10Y
Leveragex
1.468
0.023
0.021
EBIT/Intx
0.121
0.060
0.068
Own earn%
18.40
83.78
83.88
Sh yield%
41.99
20.86
25.96
Owners
Insiders/Inst%
3.61
85.90
Short interest%
0.74
SBC / revenue%
5.71
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
7–14
$1 testx
—
Incr. ROIC%
2